COVID-19 Treatment Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2021 - 2027

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global COVID-19 Treatment Market, By Type

7.1.  COVID-19 Treatment Market, By Type, 2020-2027

7.1.1.    Treatment

7.1.1.1.        Market Revenue and Forecast (2016-2027)

7.1.2.    Severity Degree

7.1.2.1.        Market Revenue and Forecast (2016-2027)

Chapter 8.  Global COVID-19 Treatment Market, By Application

8.1.  COVID-19 Treatment Market, By Application, 2020-2027

8.1.1.    Children

8.1.1.1.        Market Revenue and Forecast (2016-2027)

8.1.2.    Adult

8.1.2.1.        Market Revenue and Forecast (2016-2027)

8.1.3.    Special Groups

8.1.3.1.        Market Revenue and Forecast (2016-2027)

8.1.4.    Special groups refers to pregnants

8.1.4.1.        Market Revenue and Forecast (2016-2027)

Chapter 9.  Global COVID-19 Treatment Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, By Type (2016-2027)

9.1.2.    Market Revenue and Forecast, By Application (2016-2027)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, By Type (2016-2027)

9.1.3.2.        Market Revenue and Forecast, By Application (2016-2027)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, By Type (2016-2027)

9.1.4.2.        Market Revenue and Forecast, By Application (2016-2027)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, By Type (2016-2027)

9.2.2.    Market Revenue and Forecast, By Application (2016-2027)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, By Type (2016-2027)

9.2.3.2.        Market Revenue and Forecast, By Application (2016-2027)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, By Type (2016-2027)

9.2.4.2.        Market Revenue and Forecast, By Application (2016-2027)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, By Type (2016-2027)

9.2.5.2.        Market Revenue and Forecast, By Application (2016-2027)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, By Type (2016-2027)

9.2.6.2.        Market Revenue and Forecast, By Application (2016-2027)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, By Type (2016-2027)

9.3.2.    Market Revenue and Forecast, By Application (2016-2027)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, By Type (2016-2027)

9.3.3.2.        Market Revenue and Forecast, By Application (2016-2027)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, By Type (2016-2027)

9.3.4.2.        Market Revenue and Forecast, By Application (2016-2027)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, By Type (2016-2027)

9.3.5.2.        Market Revenue and Forecast, By Application (2016-2027)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, By Type (2016-2027)

9.3.6.2.        Market Revenue and Forecast, By Application (2016-2027)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, By Type (2016-2027)

9.4.2.    Market Revenue and Forecast, By Application (2016-2027)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, By Type (2016-2027)

9.4.3.2.        Market Revenue and Forecast, By Application (2016-2027)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, By Type (2016-2027)

9.4.4.2.        Market Revenue and Forecast, By Application (2016-2027)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, By Type (2016-2027)

9.4.5.2.        Market Revenue and Forecast, By Application (2016-2027)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, By Type (2016-2027)

9.4.6.2.        Market Revenue and Forecast, By Application (2016-2027)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, By Type (2016-2027)

9.5.2.    Market Revenue and Forecast, By Application (2016-2027)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, By Type (2016-2027)

9.5.3.2.        Market Revenue and Forecast, By Application (2016-2027)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, By Type (2016-2027)

9.5.4.2.        Market Revenue and Forecast, By Application (2016-2027)

Chapter 10.  Company Profiles

10.1.              Codagenix

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              GeoVax Labs, Inc.

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Takis Biotech

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Evvivax

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Zydus Cadila

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              MIGAL Galilee Research Institute

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Generex Biotechnology Corporation

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Moderna Therapeutics

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Novavax

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           Bravovax

10.10.1.               Company Overview

10.10.2.               Product Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

10.11.           Ascletis Pharma

10.11.1.               Company Overview

10.11.2.               Product Offerings

10.11.3.               Financial Performance

10.11.4.               Recent Initiatives

10.12.           Janssen Pharmaceuticals

10.12.1.               Company Overview

10.12.2.               Product Offerings

10.12.3.               Financial Performance

10.12.4.               Recent Initiatives

10.13.           Altimmune

10.13.1.               Company Overview

10.13.2.               Product Offerings

10.13.3.               Financial Performance

10.13.4.               Recent Initiatives

10.14.           Greffex Inc.

10.14.1.               Company Overview

10.14.2.               Product Offerings

10.14.3.               Financial Performance

10.14.4.               Recent Initiatives

10.15.           CanSino Biologics, Inc.

10.15.1.               Company Overview

10.15.2.               Product Offerings

10.15.3.               Financial Performance

10.15.4.               Recent Initiatives

10.16.           ExpreS2ion Biotechnologies ApS

10.16.1.               Company Overview

10.16.2.               Product Offerings

10.16.3.               Financial Performance

10.16.4.               Recent Initiatives

10.17.           Clover Biopharmaceuticals

10.17.1.               Company Overview

10.17.2.               Product Offerings

10.17.3.               Financial Performance

10.17.4.               Recent Initiatives

10.18.           Vaxil Bio Ltd.

10.18.1.               Company Overview

10.18.2.               Product Offerings

10.18.3.               Financial Performance

10.18.4.               Recent Initiatives

10.19.           iBio Pharma Inc

10.19.1.               Company Overview

10.19.2.               Product Offerings

10.19.3.               Financial Performance

10.19.4.               Recent Initiatives

10.20.           Tonix Pharmaceuticals

10.20.1.               Company Overview

10.20.2.               Product Offerings

10.20.3.               Financial Performance

10.20.4.               Recent Initiatives Initiatives

10.21.           Curevac

10.21.1.               Company Overview

10.21.2.               Product Offerings

10.21.3.               Financial Performance

10.21.4.               Recent Initiatives Initiatives

10.22.           ImmunoPrecise

10.22.1.               Company Overview

10.22.2.               Product Offerings

10.22.3.               Financial Performance

10.22.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms

Report Details

  • Report Code:35264
  • Category:Healthcare
  • No. of Pages:250
  • Format:PDF/PPT/Excel
  • Published:November 2020
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers